Skip to main content
Clinical Trials/NCT05232799
NCT05232799CompletedNot Applicable

Community Paramedic Hospitalization Reduction and Mitigation Program: Pragmatic Clinical Trial

Mayo Clinic2 sites in 1 country250 target enrollmentStarted: January 21, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
250
Locations
2
Primary Endpoint
Number of days spent outside the hospital and ED

Study Overview

Brief Summary

The purpose of this research is to compare the effectiveness of the Care Anywhere with Community Paramedics program with usual care in a pragmatic randomized controlled trial. The goal of the Care Anywhere with Community Paramedics program is to prevent or shorten hospitalizations among patients who are being treated in the clinic/ambulatory setting ("prehospital setting"), emergency department, or hospital and are clinically appropriate to be cared for at home with community paramedic services.

Detailed Description

This pragmatic randomized controlled trial will randomize, with 1:1 allocation, 240 adults being treated in the pre-hospital setting, emergency department or hospital to either availability of the Care Anywhere with Community Paramedics (CACP) program or to no availability of the CACP program (i.e. usual care). Patients randomized to the CACP program will be able to receive in-home medical care - as ordered by their treating clinicians - from the Mayo Clinic Ambulance Community Paramedic Service. Primary outcome is going to be days alive spent at home without hospitalization (excluding planned admissions), emergency department visits, or skilled nursing facility care.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult (age ≥ 18 years) patients currently admitted to the ED, hospital or are in a pre-hospital setting but being considered for referral to the ED or hospital in Mayo Clinic Rochester, MN and Barron, WI but do not require hospital-level monitoring or care other than services that could be delivered by CPs in the ambulatory setting.
  • •Must reside within approximately a 40-mile radius of Rochester, MN or within the service radius of Barron, WI.
  • •Participants who require assistance with activities of daily living, or who are at increased risk for falls, need to have a caregiver available at home

Exclusion Criteria

  • •Referring clinician and the community paramedic service do not believe the patient to be clinically appropriate for outpatient care with the CACP program.
  • •Inability or unwillingness of individual or legal guardian/representative to give written informed consent.
  • •Clinical, behavioral, or cognitive instability, determined by the referring clinician or the CACP service.
  • •Living conditions unsafe for CPs to enter (patient refuses to secure weapons or animals prior to CP's arrival).
  • •Enrolled in the trial during an earlier hospitalization or ED visit.

Arms & Interventions

Care Anywhere with Community Paramedics program

Experimental

Subjects will be discharged from a pre-hospital setting, Emergency Department or the hospital with community paramedic services ordered and overseen by the treating clinical team per current standard of care.

Intervention: Care Anywhere with Community Paramedics program (Other)

Standard of Care

No Intervention

Subjects will receive continued usual care

Outcomes

Primary Outcomes

Number of days spent outside the hospital and ED

Time Frame: 30 days

The number of days spent outside the hospital and ED during the 30 days following enrollment to the trial. (not in the hospital, ED, or nursing home; not counting planned admissions)

Secondary Outcomes

  • CACP Program patient satisfaction(30 days)
  • Community Paramedic satisfaction with the CACP program(30 days)
  • Health related quality of life(30 days)
  • Referring clinician satisfaction with the CACP program(30 days)
  • Treatment burden(30 days)
  • Patients with an ED visit hospitalization or death(30 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Rozalina G. McCoy

Principal Investigator

Mayo Clinic

Study Sites (2)

Loading locations...

Similar Trials